July 17, 2023

BioFluidica is currently seeking pregnant women aged 18 years and older in the early stages of pregnancy, specifically between 7-13 weeks for a prenatal blood study that aims to advance cell-based noninvasive prenatal testing (cbNIPT) by isolating fetal cells from a simple blood draw, providing valuable insights into the baby’s genetic composition. As a token of appreciation, participants accepted by BioFluidica will receive $100 compensation and their baby’s gender revealed for their invaluable contribution to this research study.